BioLargo, Inc. · OTC:BLGO

BioLargo — Shareholder Meeting (May 2018)

43 slides from BioLargo's shareholder meeting presentation, May 23, 2018

  1. Slide 1: BioLargo: A Sustainable Technology Incubator

    b BioLargo We Make Life Better A Sustainable Technology Incubator Overview for Stockholder’s Meeting May 23, 2018 Stock Symbol: BLGO Westminster, CA Sefe Harbor Statement The tetomens cote ere whch arene oko fnordolingsaemets thar sls and unease etl eukst matt rm thee xed he raring tremens ning bt e

  2. Slide 2: Two Active, Two in Development

    Two Active, Two in Development - All Large Opportunities af -) ov E a | J 27 5 2 v a El 2 ya 7 CupriDyne ) ¢ (GNM) Odor-No-More (ba Chane g 3 J 3 Cc yy 2 \G}BioLargo s XY

  3. Slide 3: Platform Technology Incubator

    Platform Technology Incubator (5 BioLargo * 17 patents issued, 5 pending * Approximately $13 Million invested in product development + We incubate platforms to market- readiness, then: Y Licensure _e. ¥ Joint Venture High Tech Innovation Awards v IP Sale ——_ Y Direct-to-Market 2017 WINNER

  4. Slide 4: The Iodine Cycle - Nature Shows Us the Way!

    The Iodine Cycle - Nature Shows Us the Way!

  5. Slide 5: Collaborations, Grants, Awards

    Collaborations, Grants, Awards (BioLargo (£55 government grants) UCLA |UNIVERSITY OF SASKATCHEWAN, Environmental Research & Education Foundation Alberta NAC-IRAP innovates i Oak EPCOR Teeimeeoy 2S susTaIn CRSNG @® syecrude ho inno STARS : a High Tech Innovation Awards 2037 WINNER (a) university oF

  6. Slide 6: Growth Strategy

    Growth Strategy “We Make Life Better” Zw CupriDyne’ @cuvra (Corte an 4940S er 6 BioLargo PARTNER

  7. Slide 7: Offered by: Odor No More

    Offered by: Odor No More®, | ABioLargo® portfolio company Symbol:BLGO Sofe Harbor Statement The totement contained herein which ae not historical ae forward looking statements that are cubject to rsks and uncertonties that could enue tual recut to dir matertlly From those expressed i the oneard ooki

  8. Slide 8: First Major Commercial Success

    First Major Commercial Success — CupriDyne Clean Industrial Odor & VOC Control Bete? “Finally a product that actually works” * Market entry requires customer trust - landfill operator * Word is out; sales expanding * 3 National Purchasing Agreements with top solid waste companies. * Currently expand

  9. Slide 9: CupriDyne Clean Industrial Odor Control

    CupriDyne Clean® Industrial Odor Control — Bigk2rge Cupribyne Clean Dilution Time after Odor intensity application factor application (1-5) Eliminates VOCs, ammonia, Nor on CHGS Mist 10:1 6Ominutes 1-2 Spray 10: 60minutes 1-2 sulfur compounds, mercaptans, jy, 01 6Ominutes__12 fatty acids No masking

  10. Slide 10: Why CupriDyne Clean

    Why CupriDyne Clean® (Biokargo pr —_ Department of Pesticide Regulation ce) v Safe & Easy to Use v Environmentally Friendly é £250 ‘ost savings 0 fy - v Wide Range of Efficacy & 50% for customers Applications v Prevents evaporation and sublimation & the loss of Nitrogen for enhanced fertilizer value

  11. Slide 11: CupriDyne Clean in Action!

    CupriDyne Clean in Action! ( BioLergo ONM) Odoxr-No-Nore”

  12. Slide 12: CupriDyne Clean in Action!

    i ion! 6 BioLargo CupriDyne Clean in Action! u

  13. Slide 13: CupriDyne Clean in Agriculture

    CupriDyne Clean in Agriculture ( BioLargo Overhead and exhaust duct misting for odor elimination and livestock respiratory health

  14. Slide 14: Rapid Adoption in the USA

    Rapid Adoption in the USA (5 BioLargo * 3 of top 7 Solid Waste companies signed National Purchasing Agreements * Sales growing - 100% per quarter in 2017 * Systematic Adoption 2018 * Featured in WEF Odor Conference 2018 * “best practices” for flagship water utility

  15. Slide 15: Market Opportunity - Landfills

    Market Opportunity - Landfills Site Type Landfills 6 BioLargo MICU re 3% market 5% market sites(US revenue [BIEN share Market)" per site per year? 1,900 $120,000 $6,840,000 $11,400,000 10% market 20% market share share $22,800,000 $45,600,000 + Approximately 275 landfills operated by our NPA clients

  16. Slide 16: Market Opportunity - Transfer Stations

    Market Opportunity ; - Transfer Stations oma 10% market 20% market 3% market 5% market share share share share Potential Potential sites(US revenue Market)" per site per year? Transfer 7,600 $48,000 $10,944,000 $18,240,000 $36,480,000 $72,960,000 Stations + Approximately 300 transfer stations operat

  17. Slide 17: Market Opportunity - Wastewater Treatment Plants

    Market Opportunity - Wastewater Treatment Plants ( BioLargo Pr eel 3% market 5% market 10% market 20% market sites(US revenue [Bite share share share Market)" persite 2 per year? Wastewater 15,000 $48,000 $21,600,000 $36,000,000 $72,000,000 $144,000,000 Treatment Plants (wwT) re to Act, The Economie

  18. Slide 18: Testimonies

    Testimonies A single application from a water truck mitigated excessive odors for FIVE days at a windrow composting facility. = NY Compost Facility A 30-day trial through a transfer station misting system eliminated odors from food waste at 10 feet. - CA Transfer Station A single application with a

  19. Slide 19: BioLargo Engineering - World-Class Talent

    BioLargo Engineering — World-Class Talent + Veterans from Shaw and CB&l with 200+ years field experience 6 BioLargo + First 10+ clients under contract (small) BioLargo * Internal and external work nore ray hare + Synergy with ONM (multiple bids outstanding) > See www.biolargoengineering.com for full

  20. Slide 20: BLEST Success

    BLEST Success (5 BioLargo + $678M biofuels production plant- BLEST under contract as “owner's engineer” + $1.3 Bid Requested for Major Oil Company + +40 Projects in the Queue / Bids Out * Projecting Positive Cash Flow - Near Term \O} BioLarg Engineering BioLargo

  21. Slide 21: Track Record

    Track Record (sBioLargo \©} BioLargo Engineering, Science & Technologies * Substantial DOD & DOE Work * Project leadership in Katrina Recovery & Haiti rebuilding efforts + Developed technology solution to eliminate Anthrax from notable US landmark buildings * Developed ammonium bicarbonate technolog

  22. Slide 22: Advanced Wound Care

    Advanced Wound Care - . BioL Disrupter in $18 Billion Global Market! b morr2f90 * Commercial Focus Awaiting FDA approval + (Office Combination Products in Process) * Second product to file soon FDA 510 (k) (more in pipeline) * ‘The gold standard - without the collateral damage’ * Infection Control =

  23. Slide 23: Clyra Advantage - Best-in-class Comparison

    Clyra Advantage - Best-in-class Comparison r( BioLargo Silver dr Attribute Cost Bacterial Resistance Delivered in Dosage Delivery Method Staining Toxic Fungicidal Nutrient Release Duration Copper Release Effective Against Biofilm Silver Dressings Expensive Controversial Yes Impregnated Yes CLYRA Dre

  24. Slide 24: Clyra Execution Strategy

    Clyra Execution Strategy 6 BioLargo Invent product and ane into -—> Patent —| wen J V Spin-Off Clyra Clinical Work to from BioLargo to EDEN pore Expand Marketing Maximize Shareholder Value & We are here - application in process

  25. Slide 25: Advanced Oxidation System (AOS)

    Advanced Oxidation System (AOS) (5 BioLargo LOW COST SOLUTION (OPEX AND CAPEX) LOW POWER CONSUMPTION ELIMINATES RECALCITRANT CONTAMINANTS O BioLargo’ Wate}

  26. Slide 26: AOS - Proven Super Oxide Generation

    AOS - Proven Super Oxide Generation (4 5SisLargo + AOS produces highly reactive iodine oxides + Proven at world-famous Canadian Light Source * Traditional iodine used in disinfection is in the form of I). @ he

  27. Slide 27: AOS - Proven Super Oxide Generation

    AOS - Proven Super Oxide Generation (4 BioLargo Molecule NR G a Free Radical (OH) TImportantin breakdown of organics Ozone (05) r Very reactive, associated with DBP Hydrogen Peroxide (H,0;) i Important in breakdown of organics Well-known oxidizing agent used in disinfection for decades ine Dioxide (

  28. Slide 28: MWD ICP-Sponsored Case Studies

    MWD ICP-Sponsored Case Studies (5 Biokargo Two Case Studies sponsored by the Metropolitan Water District of Southern California’s Innovative Conservation Program (ICP). > Official report on these studies can be found here at ICP’s website. Poultry processing wastewater case Municipal wastewater tert

  29. Slide 29: Poultry Processing Wastewater - Attractive First Market

    Poultry Processing Wastewater - Attractive First Market ‘conPORATE WATER STEWARDSHIP Investor pressure mounts on livestock water 6 BioLargo . ; INVESTOR INTERVENTION + Water scarcity + environmental clamp- down + mounting fines = attractive beachhead market + AOS is potential low-cost solution to ma

  30. Slide 30: Pilot in Poultry Industry - Fall 2018

    Pilot in Poultry Industry - Fall2018 = (BioLargo * On-site pilot project at commercial poultry processing facility + Funding secured (NRC-IRAP): CAD $235,000 + Partner location secured + Facility does 6,000-8,000 chickens/week gore oceation traton

  31. Slide 31: Potential AOS Markets

    Potential AOS Markets (5 Biokargo Near-term targets + Agricultural / Livestock / F&B wastewater reuse * Tertiary municipal wastewater polishing step * Oil & Gas Others + Data centers + Industrial wastewater * Storm water * Pharmaceuticals + Mining

  32. Slide 32: AOS Development History

    AOS Development History ( Biokargo

  33. Slide 33: BioLargo Water: Milestones

    Oéiterge Water BioLargo Water: Milestones Achieved Upcoming * Increased flow rates * Pre-commercial pilot on site * Identification of alternative with Sunwarks Farms packing materials * Toxicity studies * Expansion of scope to * Identification of DBP and any include endocrine disruptors, required mi

  34. Slide 34: Water Treatment Technologies: Development Stages

    Osictage water Water Treatment Technologies: Development Stages ot stage sing stay care out Aasresig ndaentaengnesng paren fees, ee ee ee ee sarin crams tgcet Sen mie seacthe "“eenece a Sali Teeerles Sa etchant cetera cts oueshelaen mien cence saevaramncacocinee womendieametmrnte Developed by BleTec

  35. Slide 35: Typical Commercialization Timelines

    (6) BioLargo’ Water Typical Commercialization Timelines ‘Technology Stage |Timeneeded | Cumulative Total Time | AOS Actual time spent RED fries (4 to 20+) years ‘We launched our pilot project, In Apel 2018, Pilot (2-4)* years 3° Years 15 years a | ns . gem, Working on locating funds for Demonstratio

  36. Slide 36: Typical Commercialization Timelines

    (6) BioLargo’ Water ANADA Typical Commercialization Timelines Tes wt wee ad an On Bue AOS total time (since 2014) to early commercial = 7.5 years

  37. Slide 37: Poultry Wastewater

    Osicterae eter Poultry Wastewater * Great success treating water for reuse applications waist guage cals ftlcatloms 800 NTU count (crunk) ccruymy — (FU/E toe, sos we ° ° 0 sos a me * AOS Alpha Field Pilot for treatment of poultry water initiated ‘Worked funded by Metropolitan Water District of South

  38. Slide 38: First Target Market: Poultry Processing

    Oéiterge Water First Target Market: Poultry Processing Poultry processing = water intensive process High costs associated with fresh water consumption and discharge of generated wastewater (high BOD, COD, and TSS) Significant potential to treat and recycle water for reuse AOS has small footprint, lo

  39. Slide 39: Proof of Concept: Protozoa

    joLargo’ Water (6) Proof of Concept: Protozoa * Parasite removal by the AOS approaches a 3-log reduction; combination of destruction by the AOS and loss of viability of recovered parasites Figure 1, A. Dead Giardia cyst post AOS treatment photographed with FITC+PI and PI alone; 8. Dead Cryptosporidi

  40. Slide 40: Proof of Concept: Endocrine Disruptors

    Osictarge Water Proof of Concept: Endocrine Disruptors * 100% removal of naphthenic acids * Demonstrated removal of antibiotics from wastewater * Exciting results! Conventional technologies inefficiently removes these compounds

  41. Slide 41: New packing materials and scaffolding

    OBictarge water New packing materials and scaffolding * Graphite Foam + Improved performance and durability compared to expanded graphite; ease of packing + Alternative Configurations + Improved efficiency + Reduced footprint

  42. Slide 42: Financial status

    Financial status (p BioLergo {stock Symbol BLGO Current Approximate Price: $0.26 Shares Outstandin 121 Million* Market Cap: $32M | + Commerce: ‘Two active commercial operations - sales increasing, 3"! target to be online in 2018 - 4* target late 2018/2019 ‘Three National Purchasing Agreements expand

  43. Slide 43: Stock Symbol: BLGO

    ———— Stock Symbol: BLGO Dennis Calvert President & CEO BioLargo, Inc. 14921 Chestnut St. Westminster, CA 92683 (949) 643-9540 x2 dc@biolargo.com y} BioLargo The BioLargo ‘C} Rep rare: Family of Companies BioLargo, Inc. is a sustainable science, technology & full-service environmental engineering com

BioLargo — Shareholder Meeting (May 2018) on 6ix